AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 146 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,000 | -68.6% | 15,482 | 0.0% | 0.00% | – |
| Q4 2021 | $35,000 | -22.2% | 15,482 | 0.0% | 0.00% | – |
| Q3 2021 | $45,000 | -23.7% | 15,482 | 0.0% | 0.00% | – |
| Q2 2021 | $59,000 | +13.5% | 15,482 | 0.0% | 0.00% | – |
| Q1 2021 | $52,000 | +20.9% | 15,482 | 0.0% | 0.00% | – |
| Q4 2020 | $43,000 | +10.3% | 15,482 | 0.0% | 0.00% | – |
| Q3 2020 | $39,000 | -81.4% | 15,482 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $210,000 | +377.3% | 15,482 | +167.9% | 0.00% | – |
| Q1 2020 | $44,000 | +18.9% | 5,779 | 0.0% | 0.00% | – |
| Q4 2019 | $37,000 | +60.9% | 5,779 | 0.0% | 0.00% | – |
| Q3 2019 | $23,000 | -17.9% | 5,779 | 0.0% | 0.00% | – |
| Q2 2019 | $28,000 | -40.4% | 5,779 | 0.0% | 0.00% | – |
| Q1 2019 | $47,000 | +9.3% | 5,779 | -26.0% | 0.00% | – |
| Q4 2018 | $43,000 | -2.3% | 7,812 | +57.0% | 0.00% | – |
| Q3 2018 | $44,000 | -12.0% | 4,977 | 0.0% | 0.00% | – |
| Q2 2018 | $50,000 | +150.0% | 4,977 | +136.9% | 0.00% | – |
| Q1 2018 | $20,000 | – | 2,101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $10,515,000 | 10.70% |
| Orchard Capital Management, LLC | 1,593,531 | $3,601,000 | 1.06% |
| Nantahala Capital Management | 4,918,565 | $11,116,000 | 0.39% |
| Ardent Capital Management, Inc. | 168,811 | $382,000 | 0.25% |
| Birchview Capital, LP | 100,000 | $226,000 | 0.15% |
| Nantahala Capital Management | 1,000,000 | $2,260,000 | 0.08% |
| PDT Partners, LLC | 433,400 | $979,000 | 0.08% |
| Woodline Partners LP | 2,231,966 | $5,044,000 | 0.07% |
| Virtus ETF Advisers LLC | 69,015 | $156,000 | 0.06% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,737,900 | $6,188,000 | 0.04% |